Evaluation of Bna.SCT and Bna.REF1 as Target Genes to Reduce Sinapine in Rapeseed Using a Protoplast‐Based CRISPR RNP Approach Authors: Oliver Moss, Xueyuan Li, Selvaraju Kanagarajan, Eu Sheng Wang, Emelie Ivarson, Li‐Hua Zhu Published: 2026 ABSTRACT ABSTRACTRapeseed is a major oil crop worldwide, producing both oil and a high amount of protein. However, the use of its seed meal as a protein source for animal feed is limited by antinutritional factors, such as sinapine, which reduces nutrient absorption and affects the palatability. Efforts to reduce sinapine levels through conventional breeding have had limited success. Given the challenges of a changing climate and a growing global population, maximising crop utility, particularly the value of seed meal as a byproduct, is increasingly important. Genetic modification has been successfully used to reduce sinapine in rapeseed, but regulatory restrictions limit its commercial adoption in some regions. CRISPR‐Cas gene editing, which is gaining broader global acceptance, offers a promising alternative to directly produce transgene‐free mutants. In this study, we build on our previous work by generating transgene‐free rapeseed mutants using protoplast‐based CRISPR RNP gene editing. We successfully targeted the Bna.SCT and Bna.REF1 genes with editing efficiencies of 22%–63%, frequently achieving mutations in all four alleles of the target genes in T2 plants with a single sgRNA. Seed sinapine content was reduced by up to 38% in Bna.SCT mutants and 77% in Bna.REF1 mutants, with no observed effects on plant growth or development. These findings suggest that Bna.REF1 is the most effective target for sinapine reduction in transgene‐free mutants among the genes tested in our lab. Introduction Rapeseed ( Brassica napus L.) is a major oilseed crop in temperate regions, valued for both its high‐quality oil and its protein‐rich fraction (Cheng et al. 2022). Rapeseed meal is a promising alternative to soybean meal due to its high protein content and well‐balanced amino acid composition (Yoshie‐Stark et al. 2006). However, its broader utilization in animal feed is constrained by the presence of antinutritional compounds, particularly sinapine. This secondary metabolite impairs nutrient digestibility, contributes to bitter flavours, and causes egg taint in the eggs produced by certain poultry breeds (Kozlowska et al. 1990; Qiao et al. 2008; Ward et al. 2009). Efforts to reduce sinapine content through traditional breeding have been limited by the low natural genetic variation within rapeseed germplasm (Zum Felde et al. 2007). To overcome this limitation, mutagenesis‐based approaches such as Targeting Induced Local Lesions in Genomes (TILLING) have been employed to create low‐sinapine lines. Using TILLING, homozygous mutants for UDP‐GLUCOSE:SINAPATE GLUCOSYLTRANSFERASE (Bna.SGT) and REDUCED EPIDERMAL FLUORESCENCE1 (Bna.REF1) were generated, achieving sinapine reductions of 57% and 71%, respectively (Emrani et al. 2015). While demonstrating the feasibility of reducing sinapine without transgenic modification, TILLING remains labour‐intensive, requiring extensive mutant screening and backcrossing to eliminate unwanted background mutations. Since the early 2000s, transgenic approaches have provided further progress in sinapine reduction through RNA interference (RNAi) and antisense RNA technologies. For instance, silencing Bna.SGT via RNAi resulted in a 72% reduction (Hüsken et al. 2005), while targeting Bna.REF1 yielded a 45% reduction (Mittasch et al. 2013). Antisense suppression of FERULIC ACID 5‐HYDROXYLASE (Bna.FAH) reduced sinapine by 40% (Nair et al. 2000), and RNAi‐mediated silencing of SINAPOYLGLUCOSE:CHOLINE SINAPOYLTRANSFERASE (Bna.SCT) achieved a 52% reduction. Notably, a sinapine reduction as high as 90% was observed following simultaneous silencing of Bna.FAH and Bna.SCT (Bhinu et al. 2009). These studies collectively demonstrate that targeted genetic interventions can effectively reduce sinapine accumulation in rapeseed seeds. Despite these successes, the application of genetically modified (GM) crops remains restricted in many regions, particularly in Europe. This limitation, coupled with the demand for faster crop improvement strategies to address global food security and climate challenges, highlights the need for alternative, non‐transgenic genetic modification methods (Voss‐Fels et al. 2019). New genomic techniques (NGTs), such as CRISPR‐Cas systems, offer precise, efficient, and potentially transgene‐free solutions to crop improvement. CRISPR has been shown to accelerate breeding timelines by up to twofold compared with conventional approaches (May et al. 2023), and recent regulatory developments indicate growing acceptance of NGTs in various regions (European Parliament 2024; Rabuma et al. 2024). Using our previously established protocol for protoplast regeneration in rapeseed (Li et al. 2021), we recently demonstrated the successful generation of transgene‐free mutants via CRISPR ribonucleoprotein (RNP) mutagenesis targeting Bna.SGT (Moss et al. 2025). The resulting mutants exhibited significantly reduced sinapine levels, confirming the potential of DNA‐free CRISPR editing for metabolic trait improvement in rapeseed. Building on these findings, the present study aims to further investigate the potential of two key genes—Bna.SCT and Bna.REF1—as single‐gene CRISPR‐Cas targets for reducing sinapine content. Bna.SCT encodes SINAPOYLGLUCOSE:CHOLINE SINAPOYLTRANSFERASE, the terminal enzyme in sinapine biosynthesis that catalyses the conversion of sinapoylglucose to sinapine (Milkowski et al. 2004). Due to its seed‐specific expression (Weier et al. 2008), Bna.SCT is particularly attractive for targeted mutagenesis, as disruption of its function could lower sinapine accumulation specifically in seeds without affecting upstream phenylpropanoid intermediates essential for plant physiology. There are two Bna.SCT loci, Bna.SCT1 (C genome) and Bna.SCT2 (A genome) (Weier et al. 2008), simplifying CRISPR targeting due to the low copy number. Similarly, Bna.REF1, which functions two steps upstream of Bna.SCT in the phenylpropanoid pathway, has demonstrated potential as a sinapine reduction target. RNAi suppression of Bna.REF1 resulted in a 58% decrease in sinapine (Mittasch et al. 2013), while mutagenesis yielded a greater reduction of 71% (Emrani et al. 2015). Like Bna.SCT, Bna.REF1 exists as two paralogues, Bna.REF1_I (C genome) and Bna.REF1_II (A genome), further enhancing its suitability for CRISPR‐mediated editing. The objective of this study is to assess the efficiency of DNA‐free CRISPR‐Cas mutagenesis targeting Bna.SCT and Bna.REF1 for the generation of transgene‐free, low‐sinapine mutant lines in rapeseed. Materials and Methods Plant Material and Sterilisation Seeds used in this study were spring rapeseed ( Brassica napus L.) cv. Kumily, a doubled haploid, provided by Lantmännen, Sweden. Seeds were surface‐sterilised by gentle shaking in 70% ethanol for 15 min, followed by gentle shaking in 20% kitchen bleach for 15 min. The seeds were then washed in sterile water four times. In Vitro Seedling Growth and Growth Conditions Sterilised seeds were grown on germination medium in single‐use sterile plastic boxes. The germination medium contained half‐strength Murashige and Skoog (MS) (Duchefa), 10 g L−1 sucrose and 7 g L−1 Bacto agar at pH 5.7. The boxes were maintained in a climate chamber, which had a 16‐h photoperiod, with a light intensity of 40 μmol m−2 s−1 (cool white, fluorescent tubes). The temperatures were 23°C/18°C for day and night, respectively. Sequencing of Bna.SCT and Bna.REF1 Paralogues For sequencing the Bna.SCT and Bna.REF1 paralogues, DNA was extracted from the leaves of rapeseed cv. Kumily using the GeneJet Plant Genomic DNA Purification Mini Kit (Thermo Fisher Scientific). PCR was performed using primers (Table 1) designed using the full sequences for Bna.SCT1 (AM706349), Bna.SCT2 (AM706350), Bna.REF1_I (FN995990) and Bna.REF1_II (FN995991) from NCBI. The first 900 bp of each gene was amplified using the pJET1.2 forward sequencing primer to confirm sequence identity with the reference sequences from NCBI. After verifying 100% sequence identity, we used the NCBI reference sequences for CRISPR site prediction and sgRNA design. The PCR product was purified using NucleoSpin Gel and PCR Clean‐up, Mini kit (Macherey‐Nagel) according to the manufacturer's instructions. The purified PCR product was then cloned into the pJET1.2/blunt vector using the CloneJET PCR Cloning Kit (Thermo Scientific). Transformation was conducted using Stellar Competent Cells (Takara Bio) to propagate the recombinant plasmid. Plasmid DNA was subsequently purified from bacterial cultures with the NucleoSpin Plasmid Mini Kit (Macherey‐Nagel), yielding high‐purity plasmid DNA suitable for downstream applications. The recombinant plasmids were then sent to Eurofins (Germany) for Sanger sequencing of the genes. TABLE 1CRISPR target sequences and primers for gene sequencing and target site amplicon sequencing.Primer/sgRNASequence 5′‐3′ (sgRNA PAM in bold)PurposeSCT FTTCGCATGCAAGGCTAGTGAWhole gene amplificationSCT RCAGAGAGATTCACCATCAATCCATCWhole gene amplificationSCT amplicon FGCATGCAAGGCTAGTGACACAmplicon sequencingSCT amplicon RAGCTGCATCCAGGCCCACAmplicon sequencingREF1 FTGTCCTCTGAACATAGAGAGAGAGAWhole gene amplificationREF1 RAATGGACAAAAGAAAAACGTACTGTWhole gene amplificationREF1_I amplicon FTGTCCTCTGAACATAGAGAGAGAGAAmplicon sequencingREF1_I amplicon RGAGAAGAATCTGAGGCAGGGAAmplicon sequencingREF1_II amplicon FCCAAACGTGTAGGCAATCGAAmplicon sequencingREF1_II amplicon RGCCCCATTACTTGATGAATCCAmplicon sequencingSCTsgRNA1 CCGUUGAGCAUCUUGAUUUUGGUsgRNASCTsgRNA2 ACCAAAAUCAAGAUGCUCAACGGsgRNAREF1sgRNA1GAGAACGGUAAAUGCAACGGAGG sgRNAREF1sgRNA2TCCUGAUGGCGUGAUCAACGUGG sgRNA CRISPR target sequences and primers for gene sequencing and target site amplicon sequencing. Design of sgRNAs Geneious Prime 2024.0.5 was used to predict CRISPR sites and design sgRNAs, and its off‐target checker tool was employed to assess potential off‐target effects. Additionally, the online tool Cas‐OFFinder (Bae et al. 2014) was used to further evaluate off‐target sites (available at http://www.rgenome.net/cas‐offinder/). Two sgRNAs were designed for each gene based on the predicted CRISPR sites (Table 1; Figure 1). These were selected based on high activity scores, absence of off‐target effects, positioning within functional domains of the gene, and location in regions of high sequence homology. Schematic diagram showing the positions of two sgRNAs (sg1 and sg2) of the Bna.SCT gene (top) and Bna.REF1 gene (bottom) used for knocking out the genes. Protoplast Isolation, Transfection and Plant Regeneration Leaves from 18 to 21‐day old seedlings were used for protoplast isolation using the method described by Li et al. (2021). The transfection was carried out mainly based on the methods reported by Woo et al. (2015) and Moss et al. (2025). In brief, approximately 120,000 isolated and washed protoplasts were re‐suspended in 200 μL freshly prepared MMG solution (0.5 M mannitol, 15 mM MgCl2, 4 mM MES) in a 2 mL Eppendorf tube for transfection. The solution was mixed with 20 μL RNP complex solution [4 μL gRNA (0.1 nmol/μL), 4 μL Cas9 (5 μg/μL), and 12 μL H2O], and 220 μL freshly prepared PEG‐calcium solution [40% (w/v) PEG 4000, 0.5 M mannitol, 0.1 M CaCl2]. The reaction was incubated at room temperature and stopped after 6 min by addition of 1.5 mL W5 and gentle mixing by inversion of the tubes, followed by centrifugation for 3 min at 100g and immediate removal of the supernatant. Protoplasts were then embedded in alginate discs and cultured in 6‐well microplates, as described by Li et al. (2021). The embedded protoplasts were cultured for shoot regeneration according to the optimised protocol described in the same study. The in vitro regenerated shoots or putative mutants were rooted on the rooting medium, as described by Li et al. (2021). Once the shoots formed roots, they were transferred to soil pots and grown in the biotron growth chambers, where growth conditions were 21°C/16°C (day/night), 16 h photoperiod with a light intensity of 250 μmol m−2 s−1 and 60% humidity. Identification of Mutant Lines Naming convention for mutant lines: Mutant plants were named based on the sgRNA used and their lineage across generations. In identifiers such as SCT2‐11.5.2, the numeral immediately following the gene abbreviation (2) denotes the sgRNA used for mutagenesis (e.g., gRNA2). The subsequent dot‐separated numerals (11, 5, 2) denote the plant identifier in successive generations, starting from the initial transfected T0 line. DNA extraction: Leaf tissue was taken from in vitro regenerated shoots of putative mutants and crushed with a pipette tip in Phire Dilution Buffer (Thermo Fisher Scientific). The supernatant was used as a template for a PCR reaction using Phusion High‐Fidelity PCR Master Mix (Thermo Fisher Scientific) and gene‐specific primers (Table 1) to amplify the target region containing the sgRNA site. The PCR products were purified using GeneJET Gel Extraction and DNA Cleanup Micro Kit (Thermo Fisher Scientific), and sequenced using Sanger sequencing (Azenta Life Sciences). Evaluation of mutant lines in subsequent generations: T0 mutated lines were rooted and grown in the biotron with conditions and management according to Li et al. (2021). The seeds harvested from T0 were sown in pots and grown in the biotron. Seeds from T1 plants were analysed for sinapine content and the lines with lower sinapine contents were sown to obtain T2 seeds. Genotyping was carried out in T2 generation. Two mutant plants from each T2 line, as well as two WT, were sequenced using amplicon sequencing to acquire accurate sequences from all alleles and to elucidate the type of mutations generated. Genomic DNA was extracted from plants using the GeneJet Plant Genomic DNA Purification Mini Kit (Thermo Fisher Scientific), and PCR was performed using Illumina adapter‐linked primers to amplify the target region, which was then purified using GeneJET Gel Extraction and DNA Cleanup Micro Kit (Thermo Fisher Scientific). The samples were then sent for amplicon sequencing at Eurofins Genomics (Germany). Sinapine analysis: Sinapine analysis was carried out in all generations of mutant lines. Extraction of sinapine was performed from defatted rapeseed meal as described in Moss et al. (2025), with 3 replicates per sample. Sinapine content in the extracted samples was analysed via HPLC as described by Moss et al. (2025) on an Agilent 1260 Series HPLC system, and an Eclipse Plus C18, 3.0 × 100 mm, 3.5 μm column (Agilent). Separation was achieved with an isocratic elution of 10 mM sodium acetate, pH 4.0 (13.5% acetonitrile) at a flow rate of 1 mL/min for 6 min. Sinapine was quantified using a variable wavelength detector (VWD) at a signal wavelength of 330 nm, based on its retention time, and compared to a certified sinapine external standard (ChemFaces). Phenotypic observations: Apart from regular visual observations on growth, flowering time, seed setting, and so forth, 100‐seed weight was measured by weighing 100 seeds on a microbalance. Statistical Analysis Data was analysed via one‐way analysis of variance (one‐way ANOVA) and Tukey's honest significance test (Tukey's HSD test) at a significance level of p ≤ 0.05. Software: Minitab version 21.4.2 (64‐bit), Minitab LLC. Results Gene Sequencing The genes were amplified using the primers in Table 1. Sanger sequencing was performed using the pJET1.2 forward sequencing primer (Thermo Scientific), confirming the presence of two paralogues of Bna.SCT: Bna.SCT1 and Bna.SCT2, consistent with that by Weier et al. (2008). Similarly, two paralogues of Bna.REF1: Bna.REF1_I and Bna.REF1_II were confirmed, consistent with the sequences reported by Mittasch et al. (2013). The sequences obtained showed 100% identity with the sequences from NCBI. Mutation Efficiency For Bna.SCT, 35 shoots derived from SCTsgRNA1 and 27 from SCTsgRNA2 were initially screened via Sanger sequencing of PCR products. Six SCTsgRNA1 and 22 SCTsgRNA2 derived shoots were positive for mutations in the sgRNA region, corresponding to a mutation efficiency of 22% and 63%, respectively. For Bna.REF1, 16 putative mutants derived from REF1sgRNA1 and 16 from REF1sgRNA2 were screened. Six and nine positive mutants were detected for each sgRNA, corresponding to mutation efficiencies of 38% and 56%, respectively. Genotyping by Amplicon Sequencing Positive mutants in T2 generation were genotyped using amplicon sequencing to confirm the types of mutations and assess the number of alleles carrying the mutation. For Bna.SCT, two out of the 12 plants from both T2 mutant lines were genotyped. Both SCT2.11.3 lines had mutations on all four alleles of Bna.SCT; however, one out of the four alleles contained a silent mutation (SCT2.11.3.9 Bna.SCT1 allele 2, SCT2.11.3.10 Bna.SCT2 allele 2), meaning that three out of four alleles were mutated (Figure 2). In contrast, both SCT2.11.5 lines carried meaningful mutations (stop codon or frame shift) on all four alleles. Types of mutations in Bna.SCT detected in T2 rapeseed mutants derived from SCTsgRNA2 in comparison with wild type (WT), determined by amplicon sequencing. Mutations are indicated by red letters (insertions), ‘–’ (deletions), or blue letters (substitutions). PAM sites are highlighted in bold letters. SCT2 refers sgRNA2 and numbers after the dash denote plant numbers across the T0–T2 generations. For Bna.REF1, two out of the 12 plants of all T1 mutant lines were genotyped. The results showed that all plants were mutated in both alleles of both paralogues of Bna.REF1 apart from plant REF1.4.2, which was mutated in one out of four alleles (Figures 3 and 4). Types of mutations in the REF1gene detected in T1 rapeseed REF1mutants in comparison with wild type (WT), determined by amplicon sequencing. Mutations are indicated by red letters (insertions), PAM sites are highlighted in bold letters. REF1 refers to sgRNA1 and numbers after the dash denote plant numbers in the T0 and T1 generations. Types of mutations in Bna.REF2 detected in T1 rapeseed REF1sgRNA2 mutants in comparison with wild type (WT), determined by amplicon sequencing. Mutations are indicated by red letters (insertions), ‘–’ (deletions), or blue letters (substitutions). PAM sites are highlighted in bold letters. REF2 refers sgRNA2 and numbers after the dash denote plant numbers across the T0–T2 generations. Sinapine Content For Bna.SCT mutants in T0 generation, three plants derived from SCTsgRNA1 and three derived from SCTsgRNA2 were grown in the biotron for phenotyping. The sinapine analysis results for the T0 mutants are presented in Figure S1. The seed sinapine content in most mutant lines was similar to that of WT, except line SCT2.11, which showed slightly reduced sinapine content, and line SCT2.12 with an increased sinapine content, possibly due to not all alleles of Bna.SCT being mutated. Two plants derived from sgRNA1 (SCT1.20 and SCT1.24) and two plants derived from sgRNA2 (SCT2.5 and SCT2.11) were selected for growth in the next generation (T1). Five seeds from each line were grown in the biotron. The average sinapine level in line SCT2‐11 showed a significant reduction compared to WT, while a significant increase in sinapine level in line SCT2‐5 was observed (Figure 5). When looking at the individual plant level, only two plants from the line SCT2.11 had clearly reduced sinapine contents compared to WT, while the rest of the plants in different lines had little difference, or even increased sinapine levels (Figure S2). Mean seed sinapine content in T1 Bna.SCT knockout rapeseed lines compared with wild type (WT), based on Figure S2. Different letters above the bars represent significant differences at p ≤ 0.05 with Tukey's HSD test. Error bars represent ± SD (n = 5 individual plants). SCT1 and SCT2 refer to sgRNA1 and sgRNA2, respectively. Numbers after the dash denote plant numbers in the T1 generation. Twelve seeds from the two T1 lines 3 and 5 with the lowest sinapine contents, SCT2.11.3 and SCT2.11.5, were planted for the next generation (T2). The average sinapine reduction for SCT2.11.3 and SCT2.11.5 was 27% and 31%, respectively (Figure 6). The individual mutant with the lowest sinapine was SCT2.11.3.10, which had 6.6 mg/g sinapine in the seed, or a reduction of 38% (Figure S3). Mean seed sinapine content in T2 Bna.SCT knockout rapeseed lines compared with wild type (WT), based on Figure S3. Different letters above the bars represent significant differences at p ≤ 0.05 with Tukey's HSD test. Error bars represent ± SD (n = 12 individual plants). SCT2 refers to sgRNA2 and numbers after the dash denote plant numbers in the T0 and T1 generations. For Bna.REF1 mutants in T0 generation, four positive mutants derived from REF1sgRNA1 and four from REF1sgRNA2 were analysed for seed sinapine content (Figure S4). Two plants derived from REF1sgRNA1 and two plants derived from REF1sgRNA2 were selected for further evaluation in the T1 generation (REF1.3, REF1.4, REF2.4, REF2.7), based on their reduced sinapine levels. The seed sinapine levels in individual plants in each mutant line showed a consistent sinapine reduction for all lines, apart from REF1.4, due to the line segregating (Figure S5). The average sinapine content in all lines had a significant reduction in comparison to WT (Figure 7). Mean seed sinapine content in T1 Bna.REF1 knockout rapeseed lines compared with wild type (WT), based on Figure S5. Different letters above the bars represent significant differences at p < 0.05 with Tukey's HSD test. Error bars represent ± SD (n = 12 individual plants). REF1 and REF2 refer to sgRNA1 and sgRNA2, respectively. Numbers after the dash indicate plant numbers in the T1 generation. The T1 Bna.REF1 mutant line with the lowest sinapine was REF1.1.3, with an average sinapine level of 2.9 mg/g, or a reduction of 73%. The individual mutant with the lowest sinapine had a value of 2.44 mg/g, corresponding to a 77% reduction. Line REF1.4 had a mixture of plants with reduced and normal sinapine levels. Genotyping of one of the low and one of the normal sinapine plants (REF1.4.10 and REF1.4.2, respectively) within this line showed that the low sinapine plant carried knockout mutations in all four alleles, whereas the normal sinapine plant carried a knockout mutation in one out of four alleles (Figure 3). This suggests that line REF1.4 is segregating. Phenotypic Observation The Bna.SCT lines exhibited normal growth comparable to the WT, but the 100‐seed weight of the Bna.SCT lines was greater than those of WT plants (Figure 8). Similarly, all Bna.REF1 lines displayed growth and flowering times consistent with WT. While most Bna.REF1 lines had 100‐seed weights similar to WT, seeds from REF1‐4 were notably heavier (Figure 9). 100‐seed weight of Bna.SCT mutants in the T2 generation and wild type (WT) of rapeseed. Different letters above the bars represent significant differences at p ≤ 0.05 with Tukey's HSD test. Error bars represent ± SD (n = 12 individual plants). SCT2 refers to sgRNA2. Numbers after the dash denote plant numbers in the T1 and T2 generations. 100‐seed weight of Bna.REF1 mutants in the T1 generation and wild type (WT) of rapeseed. Different letters above the bars represent significant differences at p ≤ 0.05 with Tukey's HSD test. Error bars represent ± SD (n = 12 individual plants). REF1 and REF2 refer to sgRNA1 and sgRNA2, respectively. Numbers after the dash denote plant numbers in the T1 generation. Discussion In this study, we built upon our previous work in Moss et al. (2025), where the protoplast regeneration protocol adapted from Li et al. (2021) was used for to generate transgene‐free, low‐sinapine mutants of rapeseed by targeting Bna.SGT. The current study extends the work of Moss et al. (2025) by evaluating two additional target genes involved in sinapine biosynthesis for CRISPR‐Cas9 editing, namely Bna.SCT and Bna.REF1, whilst further demonstrating the relative ease of generating transgene‐free mutants of rapeseed. This kind of research is particularly important due to the need for precise, faster breeding methods whilst addressing the drawbacks of other breeding techniques. Regulatory concerns and public perception limit the commercial sale of transgenic crops in Europe, and TILLING comes with practical drawbacks. Crops developed through NGTs, such as CRISPR‐Cas9, are expected to gain market approval in the near future (European Parliament 2024). The presence of two Bna.SCT genes, Bna.SCT1 and Bna.SCT2 in rapeseed cv. Kumily, confirmed by sequencing, is consistent with the findings of Weier et al. (2008). Similarly, sequencing confirmed the presence of two Bna.REF1 paralogues, Bna.REF1_I and Bna.REF1_II, in agreement with Mittasch et al. (2013). We demonstrated editing efficiencies of 22% and 63% for SCTsgRNA1 and SCTsgRNA2, and 38% and 56% for REF1sgRNA1 and REF1sgRNA2, respectively. These results further highlight the high editing efficiencies achievable for rapeseed through using our protoplast‐based CRISPR RNP editing approach. It should be borne in mind that protoplast regeneration capacity can be genotype‐dependent. It is thus possible that the efficient protocol established in this study could work directly or may need some modifications in culture media for protoplast regeneration when switching to a new genotype. The T0 Bna.SCT mutants had mixed sinapine levels, mostly with minimal changes to the sinapine content, which is likely because not all alleles of the target genes were mutated. In the T1 generation, some lines showed clear reduced sinapine content and these were selected for further evaluation in T2. The average sinapine reduction for the T2 lines SCT2.11.3 and SCT2.11.5 was 27% and 31%, respectively, and a relatively consistent sinapine reduction can be observed across individuals within the lines, particularly in SCT2.11.5. These results show that knocking out Bna.SCT influences the accumulation of sinapine in rapeseed seeds, but not to the same extent as other target genes, such as Bna.REF1 in this study, or Bna.SGT in our previous study (Moss et al. 2025). One of the main reasons we chose Bna.SCT as a CRISPR target was its position at the end of the phenylpropanoid pathway, making it less likely to disturb the rest of the pathway, causing negative consequences for the plant. However, it is possible that Bna.SCT's position in the sinapine biosynthetic pathway makes it less efficient at preventing sinapine production. Plants mutated with meaningful mutations in three out of four Bna.SCT alleles performed equally to those with meaningful mutations in all 4 alleles regarding sinapine content, indicating that a single functional Bna.SCT allele may not significantly contribute to sinapine accumulation. This is in contrast to the Bna.SGT.a mutants, in which one unmutated allele could lead to unchanged sinapine levels compared to WT (Moss et al. 2025). In this study, Bna.REF1 lines exhibited a significant reduction in sinapine, which was already evident in the T0 generation. The T1 line with the highest reduction in sinapine was REF1.1.3, with a sinapine content of 2.9 mg/g, representing a 73% reduction. The individual mutant with the lowest sinapine content recorded a value of 2.44 mg/g, corresponding to a 77% reduction. These reductions are comparable to those reported by Emrani et al. (2015), who achieved a 71% reduction using EMS mutagenesis, and notably higher than the 58% reduction observed in transgenic Bna.REF1 mutants by Mittasch et al. (2013). Additionally, our results showed that Bna.REF1 lines with mutations in only one of the four Bna.REF1 alleles exhibited little or no reduction in sinapine. This result is consistent with the findings of Harloff et al. (2012) and Emrani et al. (2015), who reported that knocking out one gene copy, affecting both of its alleles, was insufficient to lower sinapine levels. Regarding phenotypic traits of the edited lines with significantly reduced sinapine contents, we did not observe any differences in the health or well‐being of plants in the T1 generation under controlled conditions in the biotron. Further studies on the growth performance of those lines need to be carried out in field trials under natural conditions in order to ensure that knocking out Bna.REF1 does not negatively impact the plants' well‐being or agricultural properties. Previous research on transgenic Bna.REF1 knockouts did not evaluate the growth characteristics of the mutants (Mittasch et al. 2013). Nonetheless, it has been observed that Arabidopsis At.REF1 mutants showed no detectable changes in these factors compared to wild type (Nair et al. 2000). Similarly, Emrani et al. (2015) noted that their Bna.REF1 EMS mutants exhibited no differences in important growth characteristics compared to EMS controls, further supporting the evidence that Bna.REF1 knockouts do not cause adverse growth effects. One concern in reducing sinapine in rapeseed is its role in protecting the plant from UV‐B radiation. Studies on Bna.SGT mutants showed that the reduction in sinapine and sinapate esters in rapeseed caused by the silencing of Bna.SGT had no negative effect on seed germination, seedling development, or response to UV‐B radiation (Hettwer et al. 2016). These findings may indicate that reductions in sinapine content achieved through Bna.SCT and Bna.REF1 knockouts are unlikely to compromise the plant's ability to withstand UV‐B radiation. However, experimental studies are needed to prove this. Among the three genes knocked out by CRISPR RNP for reducing sinapine content in the seeds of rapeseed carried out in our lab, it appeared that Bna.REF1 proved to be the most effective at reducing sinapine, with a 77% reduction in the lowest individual plant, followed by Bna.SGT (49%) (Moss et al. 2025), while Bna.SCT showed the least sinapine reduction (38%). Further testing on phenotypic traits, plant health, and metabolism would be necessary to make a comprehensive evaluation of these mutant lines. We believe it is possible to further reduce sinapine content by further screening, as there is variation in sinapine content within mutant plants mutated in the same target gene. The most efficient way for achieving even lower sinapine levels is likely by simultaneously targeting multiple target genes. In conclusion, following from our previous work (Moss et al. 2025), we have further demonstrated the feasibility of rapidly and efficiently generating transgene‐free mutants via protoplast‐based CRISPR RNP gene editing using the protocol developed in our lab (Li et al. 2021). This approach offers a means to overcome the drawbacks of existing breeding and biotechnological techniques. Author Contributions L.H.Z. led the project and edited the draft and final version. O.M. performed experiments and analyzed data, wrote the draft and edited the final version. X.L. performed experiments. E.S.W. performed sinapine and statistical analysis. E.I. and S.K. participated in the experimental design and reviewed the final version. All authors read and commented on the previous version and agreed with the final version of the manuscript. Funding This study was mainly supported by (1) SLU Grogrund‐Centre for Breeding of Food Crops, (2) Trees and Crops for the Future (TC4F), SLU strategic research environment as well as The Royal Physiographic Society of Lund, which were provided to LHZ. Disclosure No AI is used in this manuscript. Supporting information Figure S1: Seed sinapine content in T0 Bna.SCT mutants compared with wild type (WT) of rapeseed. SCT1 and SCT2 denote sgRNA1 and sgRNA2, respectively and numbers after the dash donate mutant lines. Figure S2: Seed sinapine content in T1 Bna.SCT mutants compared with wild type (WT) of rapeseed. SCT1 and SCT2 denote sgRNA1 and sgRNA2, respectively. The numbers after the dash denote mutant line numbers, while the numbers after the dash denote plant numbers in mutant lines in the T1 generation. Figure S3: Seed sinapine content in two T2 Bna.SCT mutants and wild type (WT) of rapeseed. SCT1 and SCT2 denote sgRNA1 and sgRNA2, respectively. The number 11 after the dash denote mutant line number in T1. The numbers 3 and 5 after the first dots denote the line numbers in T2 and the last numbers after the second dots donate the plant numbers in the mutant lines 3 and 5, respectively. Figure S4: Sinapine content in the seeds of rapeseed Bna.REF1 mutants and WT in the T0 generation. Figure S5: Sinapine content in the seeds of rapeseed Bna.REF1 mutants and WT in the T1 generation.